SLC1A2 and myeloid sarcoma: Further experiments in paired relapse/remission plasma samples collected from RRMS patients, highlighted changes of EV-EAAT2 level associated with different phases of the disease overtime and confirmed the association of highest plasma EV-EAAT2 level with MS relapses.